Editorial: do thiopurines and biologics decrease the risk of colectomy? Authors' reply
Aliment Pharmacol Ther
.
2017 Nov;46(9):897-898.
doi: 10.1111/apt.14336.
Authors
C Eriksson
1
,
Y Cao
2
3
,
S Rundquist
1
,
Y Zhulina
1
,
I Henriksson
1
,
S Montgomery
2
4
5
,
J Halfvarson
1
Affiliations
1
Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
2
Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
3
Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
4
Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
5
Department of Epidemiology and Public Health, University College London, London, UK.
PMID:
29023888
DOI:
10.1111/apt.14336
No abstract available
Publication types
Editorial
Kommentar
MeSH terms
Biological Products*
Colectomy*
Colitis, Ulcerative
Humans
Risk
Substances
Biological Products